TradesZ
Top 10 stocks to add now
← All stocks
BLTE

BLTE — Belite Bio, Inc

CIK 1889109 · SEC EDGAR fundamentals

Headline figures

Revenue
—

Top-line sales for the most-recent fiscal year

Net income
-$31.6M
-150.1% vs prior year

Profit after all expenses, taxes, interest

FY2025 · 20-F

EPS (diluted)
-$1.19
-88.9% vs prior year

Net income per diluted share outstanding

FY2025 · 20-F

Op. cashflow
-$29.8M
-160.4% vs prior year

Cash actually generated by the business

FY2025 · 20-F

Balance sheet

Total assets
$152.1M

Everything the company owns

FY2025 · 20-F

Total liabilities
$6.3M

Everything the company owes

FY2025 · 20-F

Stockholders equity
$41.5M

Assets minus liabilities (book value)

FY2025 · 20-F

Long-term debt
—

Debt due more than 12 months out

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.